CVRx enables first Barostim implant access at Vassar Brother Medical Center

CVRx enables first Barostim implant access at Vassar Brother Medical Center
CVRx, Vassar center Barostim debut

CVRx has announced a partnership with Vassar Brother Medical Center for the center's first Barostim implant procedure. This collaboration gives patients at the facility access to a novel device therapy aimed at improving treatment options.

The Barostim implant is designed to address symptoms for specific patient populations, and its introduction marks a concrete operational milestone for CVRx and the medical center. Representatives from CVRx acknowledged the role of the Vassar Brother Medical Center clinical team in making this deployment possible.

Earlier this year, CVRx supported Endeavor Health's initial Barostim device implant as part of efforts to expand heart failure treatment options. The company also reported its first participant in the BENEFIT-HF trial receiving an implant in Ohio with The Christ Hospital team, marking a research milestone in the trial's progress. These developments highlight CVRx’s ongoing efforts to deploy Barostim technology in clinical settings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.